Bollard Group LLC Eli Lilly & CO Transaction History

Bollard Group LLC

$4.37 Billion
Q2 2025

A detailed history of Bollard Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bollard Group LLC holds 251,489 shares of LLY stock, worth $217 Million. This represents 4.48% of its overall portfolio holdings.

Number of Shares

251,489

Previous 240,143 4.72%

Holding current value

$217 Million

Previous $198 Million 1.16%

% of portfolio

4.48%

Previous 5.21%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$713.71 - $898.95 $8.1 Million - $10.2 Million	11,346 Added 4.72%	251,489 $196 Million
Q1 2025 May 15, 2025	BUY	$725.72 - $929.72 $179,978 - $230,570	248 Added 0.1%	240,143 $198 Million
Q4 2024 Feb 14, 2025	SELL	$727.2 - $932.06 $8.46 Million - $10.8 Million	-11,628 Reduced 4.62%	239,895 $185 Million
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $48,644 - $60,481	-63 Reduced 0.03%	251,523 $223 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $171,794 - $215,442	237 Added 0.09%	251,586 $228 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $153,379 - $205,200	259 Added 0.1%	251,349 $196 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $155,456 - $183,262	296 Added 0.12%	251,090 $146 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $133,018 - $183,385	306 Added 0.12%	250,794 $135 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $71,200 - $95,202	203 Added 0.08%	250,488 $117 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $170,225 - $199,921	548 Added 0.22%	250,285 $86 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $2.26 Million - $2.63 Million	-7,016 Reduced 2.73%	249,737 $91.4 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $59,296 - $67,574	200 Added 0.08%	256,753 $83 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $140,758 - $165,271	505 Added 0.2%	256,553 $83.2 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $539,082 - $669,943	2,297 Added 0.91%	256,048 $73.3 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $167,738 - $208,163	746 Added 0.29%	253,751 $70.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $294,063 - $361,886	1,327 Added 0.53%	253,005 $58.5 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $3.92 Million - $5.07 Million	-21,690 Reduced 7.93%	251,678 $57.8 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $4.04 Million - $5.22 Million	-24,560 Reduced 8.24%	273,368 $51.1 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $250,352 - $331,276	-1,919 Reduced 0.64%	297,928 $50.3 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $292 - $338	-2 Reduced -0.0%	299,847 $44.4 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $973,765 - $1.17 Million	-7,138 Reduced 2.33%	299,849 $49.2 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $80,239 - $99,313	674 Added 0.22%	306,987 $42.6 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $83,504 - $103,427	781 Added 0.26%	306,313 $40.3 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $88,101 - $95,832	825 Added 0.27%	305,532 $34.2 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $4.02 Million - $4.7 Million	-36,307 Reduced 10.65%	304,707 $33.8 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $142,365 - $167,574	1,279 Added 0.38%	341,014 $44.3 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $690,150 - $773,176	6,517 Added 1.96%	339,735 $39.3 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $467,250 - $583,981	5,442 Added 1.66%	333,218 $35.8 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $223,012 - $255,948	2,946 Added 0.91%	327,776 $28 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $310,197 - $366,168	4,180 Added 1.3%	324,830 $25.1 Million
Q4 2017 Jan 29, 2018	BUY	$81.94 - $87.89 $185,757 - $199,246	2,267 Added 0.71%	320,650 $27.1 Million
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $24.5 Million - $27.2 Million	318,383	318,383 $27.2 Million

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Eli Lilly & CO Transaction History